Bioorganic and Medicinal Chemistry Letters p. 2677 - 2682 (1996)
Update date:2022-08-02
Topics:
Friesen, Richard W.
Dube, Daniel
Fortin, Rejean
Frenette, Richard
Prescott, Sylvie
Cromlish, Wanda
Greig, Gillian M.
Kargman, Stacia
Wong, Elizabeth
Chan, Chi Chung
Gordon, Robert
Xu, Li Jing
Riendeau, Denis
A series of novel 2,3-diaryl-2-cyclobuten-1-ones have been synthesized and have been evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-1 and COX-2. 4,4-Dimethyl-2-phenyl-3-[4-(methylsulfonyl)phenyl]cyclobutenone 22 was found to be highly selective for inhibition of COX-2 and was orally active (ED50 = 2.4 mg/kg) in the rat paw edema model.
View MoreChangde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Jinan Jinguilin Chemical Co.,Ltd
Contact:+86-531-81188412
Address:3rd floor of Torch Building, Huanyuan Rd, City of Jinan
Contact:+1-284-4950244
Address:Box 3069, Road Town, Tortola, British Virgin Islands
Shenyang Mole pharmaceutical Technology Development Co.,Ltd
Contact:+86-24-31204918/13889278616
Address:No.44, wanliutang road, shenhe District of Shenyang
Yuan Shi(SuQian)Biotechnology Co.,Ltd
website:http://www.yuanshibio.com
Contact:+86-527-84226672
Address:jiangsu suqian
Doi:10.1016/S0960-894X(96)00561-6
(1996)Doi:10.1002/cctc.201601654
(2017)Doi:10.1002/anie.199701551
(1997)Doi:10.1016/S0040-4039(96)02196-X
(1997)Doi:10.1002/chem.19970031006
(1997)Doi:10.3797/scipharm.aut-04-02
(2004)
